INNOVA CAPTAB
|
The Current P/S Ratio of INNOVA CAPTAB is 2.72.
| Share Price | ₹713.0 | Mar 25,2026 |
| Market Cap | ₹4,078.4 Cr | |
| Sales-TTM | ₹1,497.0 Cr | TTM-Consolidated Results |
| Price/Sales | 2.72x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of INNOVA CAPTAB
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,078.4 Cr] as on Mar 25,2026
(/) Sales [ ₹1,497.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.72x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay '2.72 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of INNOVA CAPTAB !
The chart below summarizes the trend in P/S Ratio of INNOVA CAPTAB over the last five years.
Historical PS (Price/Sales) ratio chart of INNOVA CAPTAB
PS Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.28x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 4.04x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| INNOVA CAPTAB | 1,497.0 | 2.72 | 4,078.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.58 | 430,645.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.48 | 159,625.0 |
| CIPLA LTD | 28,351.1 | 3.54 | 100,480.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.41 | 145,415.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.13 | 108,664.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.99 | 83,401.6 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.49 | 90,923.3 |
| LUPIN LTD | 26,150.5 | 4.10 | 107,321.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.29 | 75,951.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.22 | 56,092.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INNOVA CAPTAB 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.29x |
| Max industry PS | 15.48x |
| Median industry PS | 4.10x |
| Average industry PS | 6.18x |
You may also like the below Video Courses